Musely

Trusper Inc. , doing business as Musely, is a Silicon Valley telemedicine company providing prescription skincare, hair, and women's hormonal care through board-certified dermatologists. Originally launched as a lifestyle and beauty tips social app, it pivoted to teledermatology in 2019 and now ships custom-compounded prescription treatments directly to patients. Founded in 2013 by Jack Jia with co-founders Rob Bradshaw, Ethan Gui, and Carrie Jiao, based in California, US, Trusper Inc is a lifestyle-tips app, then pivoted in 2019 to teledermatology under the Musely brand.

Jack Jia remains Founder and CEO. In May 2026, Musely raised approximately USD 360 million in venture debt funding from new investor General Catalyst Partners. Musely operates a telemedicine platform where patients complete an online medical questionnaire and upload skin photos for review by board-certified dermatologists. Custom prescriptions are compounded at Musely's affiliated pharmacies and shipped directly to patients.

Treatments cover melasma, acne, rosacea, hyperpigmentation, signs of aging, hair loss, and menopause-related concerns, including formulations using tretinoin, hydroquinone, tranexamic acid, and minoxidil. The eNurse follow-up tool supports ongoing dermatologist contact and progress tracking. Musely earns revenue primarily through direct-to-consumer sales of compounded prescription skincare, hair-loss, and hormonal-care treatments, with recurring purchases driving lifetime value. The vertically integrated model controls diagnosis (telehealth consultation), prescription (in-house dermatologist network), and fulfillment (affiliated pharmacy compounding).

According to the company, Musely is profitable and bootstrapped, scaling growth in 2026 with $360M in non-dilutive financing from General Catalyst's Customer Value Fund earmarked for customer acquisition. Musely’s financing from General Catalyst’s Customer Value Fund provides capital aligned with its existing revenue base, enabling the company to scale customer acquisition without equity dilution or fixed repayment pressure. The structure supports increased spend on sales and marketing, where returns are measurable and linked to customer lifetime value. Repayment through a capped share of revenue aligns investor returns with performance, making it suitable for a cash‑flow‑positive, high-growth DTC model with predictable acquisition dynamics.